Skip to Main Content

Paper Details

Deep whole genome sequencing identifies recurrent genomic alterations in commonly used breast cancer cell lines and patient-derived xenograft models.
Breast Cancer Res
3
2022
Author NameAffiliation
Andrei GogaUniversity of California san francisco
Andrei GogaUniversity of California san francisco
  • 1 - 2

Datasets

Release 1.2